Key points are not available for this paper at this time.
Evidence on the comparative outcomes following percutaneous microaxial ventricular assist devices (pVAD) versus intra-aortic balloon pump for nonacute myocardial infarction cardiogenic shock is limited.
Watanabe et al. (Tue,) studied this question.